Dumble; Melissa
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dumble; Melissa.The latest application filed is for "compositions and methods utilizing genetically-modified animals and cells".
- Dumble; Melissa - Watchung NJ
- Dumble; Melissa - Piscataway NJ
- Dumble; Melissa - Collegeville PA
| Patent | Date |
|---|---|
| Compositions And Methods Utilizing Genetically-modified Animals And Cells App 20210403945 - Levine; Arnold ; et al. | 2021-12-30 |
| Combination App 20180214451 - Dumble; Melissa ; et al. | 2018-08-02 |
| Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer Grant 9,402,846 - Dumble , et al. August 2, 2 | 2016-08-02 |
| Combination App 20160143913 - Dumble; Melissa ; et al. | 2016-05-26 |
| Pharmaceutical Combination Of Mek Inhibitor And B-raf Inhibitors App 20150111904 - Dumble; Melissa ; et al. | 2015-04-23 |
| Combination App 20150094321 - DUMBLE; Melissa ; et al. | 2015-04-02 |
| Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors Grant 8,952,018 - Dumble , et al. February 10, 2 | 2015-02-10 |
| Combination App 20140350039 - DUMBLE; Melissa ; et al. | 2014-11-27 |
| Compounds For The Modulation Of Beta-catenin Expression And Uses Thereof App 20140323557 - Dumble; Melissa ; et al. | 2014-10-30 |
| Combination App 20140309243 - DUMBLE; Melissa ; et al. | 2014-10-16 |
| Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer Grant 8,835,450 - Dumble , et al. September 16, 2 | 2014-09-16 |
| Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarbo Grant 8,796,298 - Dumble , et al. August 5, 2 | 2014-08-05 |
| Pharmaceutical Combination Of Mek Inhibitor And B-raf Inhibitors App 20140187566 - Dumble; Melissa ; et al. | 2014-07-03 |
| Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors Grant 8,703,781 - Dumble , et al. April 22, 2 | 2014-04-22 |
| Combination App 20120322817 - Dumble; Melissa ; et al. | 2012-12-20 |
| Combination App 20120283278 - Dumble; Melissa ; et al. | 2012-11-08 |
| Combination App 20120202835 - Dumble; Melissa ; et al. | 2012-08-09 |
| Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors App 20120196879 - Dumble; Melissa ; et al. | 2012-08-02 |
| Combination App 20120196886 - Dumble; Melissa ; et al. | 2012-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 